PPLPHARMANSEPiramal Pharma LimitedMediumNeutral
Announced Wed, 29 Apr · 16:45 IST

Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026

Investor Communications View source PDF

PPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.0%1-day move
₹160.56
prior close
₹161.47
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-1.5-2.3-1.3-0.0-0.4+2.7+14.3+11.8+10.9+9.0+6.2+4.6
Up moveDown movePending
AI summary

Piramal Pharma Limited has informed exchanges that the audio recording of its earnings conference call held on 29th April 2026 is now available on the company's website. The call covered the audited financial results for Q4 and the full year ended 31st March 2026 for both standalone and consolidated operations. This is a procedural disclosure under SEBI regulations requiring companies to make earnings call recordings publicly accessible. The actual financial results and any management commentary would be contained in the recording itself, which is not included in this filing.

Likely market impact

This is a standard regulatory disclosure with no direct impact on the stock. Investors interested in understanding Q4/FY2026 performance, margin trends, or any forward-looking guidance from management should access the audio recording from the company's website directly.